Cytokine-Induced Memory-like Natural Killer Cells Clinical Trials

5 actively recruiting trials across 3 locations

Also known as: CIML, CIML NK Cells, CIML NK cells, ML NK cells

Filter by location:

Boston, Massachusetts3 trials

CIML NK Cells With Venetoclax for AML

Brigham and Women's Hospital

Phase 1

Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer

Brigham and Women's Hospital

Phase 1

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

Dana-Farber Cancer Institute

Phase 1

St Louis, Missouri1 trial

Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

Washington University School of Medicine

Phase 1

Basking Ridge, New Jersey1 trial

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.